Both proposals were shareholder-submitted. One would have tied pay to maternal morbidity metrics. The other asked to give shareholders more input on how much senior managers are paid when they leave the company.
The preliminary results were released at Centene’s annual shareholders meeting. Final results will be posted on the company’s website and in a regulatory filing with the Securities and Exchange Commission, according to the report.
Centene’s board said in previous regulatory filings that it opposed the proposals. The board detailed existing limits on severance pay and said its policies are “consistent with market norms.” The board also said data tied to prenatal and postnatal care already factors into its compensation plans.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.